Stocks and Investing Stocks and Investing
Thu, August 15, 2024

Colin Bristow Maintained (ABOS) at Strong Buy with Decreased Target to $6 on, Aug 15th, 2024


Published on 2024-10-28 13:41:39 - WOPRAI, Colin Bristow
  Print publication without navigation


Colin Bristow of UBS, Maintained "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy with Decreased Target from $14 to $6 on, Aug 15th, 2024.

Colin has made no other calls on ABOS in the last 4 months.



There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with Colin's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Colin


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Wednesday, August 14th, 2024
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $7 on, Thursday, July 25th, 2024
Contributing Sources